ArticleBioinformatics advances2025
EzSEA: an interactive web interface for enzyme sequence evolution analysis.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Enzymes catalyze essential chemical reactions, driving metabolism, immunity, and growth. Understanding their evolution requires identifying mutations that shaped their functions and substrate interactions. Current methods lack integration of evolutionary history and intuitive visualization tools. Results: We develop Enzyme Sequence Evolution Analysis (EzSEA), a web interface that identifies putative functionally important mutations by performing the following steps: structural prediction, homology search, multiple sequence alignment and trimming, phylogenetic tree inference, ancestral sequence reconstruction, and enzyme delineation. The EzSEA web application enables intuitive visualization of results, highlighting key mutations and phylogenetic tree branches that putatively delineate the enzyme of interest. Finally, we validate EzSEA by identifying previously experimentally verified key mutations in the gut bacteria enzyme bilirubin reductase. Availability and implementation: EzSEA is freely available on the web at https://jianglabnlm.com/ezsea/.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.